JP Morgan Put 140 CHKP 18.10.2024/ DE000JK2H7H5 /
| 2024-05-22 10:37:32 AM | Chg.+0.010 | Bid10:00:34 PM | Ask10:00:34 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 0.290EUR | +3.57% | - Bid Size: - |
- Ask Size: - |
Check Point Software... | 140.00 USD | 2024-10-18 | Put |
GlobeNewswire
1:05 AM
Holzer & Holzer, LLC Reminds Shareholders of June 4, 2024 Lead Plaintiff Deadline in Checkpoint Ther...
GlobeNewswire
05-22
SHAREHOLDER ALERT Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint
GlobeNewswire
05-22
DEADLINE ALERT for HRT and CKPT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions...
GlobeNewswire
05-22
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Agains...
GlobeNewswire
05-22
Check Point Software Advances API Security Supporting Enterprise Digital Transformation
GlobeNewswire
05-22
Indaptus Therapeutics Announces Completion of First Patient to Receive Multiple Doses of Decoy20, th...
GlobeNewswire
05-22
OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treat...
GlobeNewswire
05-22
June 4th Lead Plaintiff Deadline Approaching in Class Action Against Checkpoint Therapeutics, Inc. –...
GlobeNewswire
05-21
Nanobiotix Announces Progress in Global NBTXR3 Development Collaboration Highlighting Robust Pipelin...
GlobeNewswire
05-21
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. wit...
GlobeNewswire
05-21
AltruBio Secures up to $225M Oversubscribed Series B Financing to Advance the Clinical Development o...
GlobeNewswire
05-21
BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO A...
GlobeNewswire
05-21
Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announ...
GlobeNewswire
05-20
DEADLINE ALERT for HRT, CKPT, SOND, QDEL: Law Offices of Howard G. Smith Reminds Investors of Class ...
GlobeNewswire
05-20
CKPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Checkpoint Therapeutics, Inc. ...
GlobeNewswire
05-20
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Checkp...
GlobeNewswire
05-20
GigaGen Doses First Patient in Phase 1 Trial of Anti-CTLA-4 Oncology Drug Candidate GIGA-564 in Adva...
GlobeNewswire
05-20
Perspective Therapeutics to Present at the Society of Nuclear Medicine and Molecular Imaging (SNMMI)...
GlobeNewswire
05-18
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Co...
GlobeNewswire
05-17
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hir...
GlobeNewswire
05-15
Molecular Templates, Inc. Reports First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire
05-15
Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
